<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03128372</url>
  </required_header>
  <id_info>
    <org_study_id>MDT16010MAVJB3</org_study_id>
    <nct_id>NCT03128372</nct_id>
  </id_info>
  <brief_title>Validation of Next Generation INVOS NIRS Cerebral and Tissue Oximeter</brief_title>
  <official_title>Validation of Next Generation INVOS NIRS Cerebral and Tissue Oximeter to Measure Cerebral and Somatic Tissue Oxygen Saturation in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to validate that the production equivalent PM7100
      System in conjunction with Adult Sensors (PMSENS71-A) meet product requirements for cerebral
      accuracy, cerebral trending accuracy, and somatic trending.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 22, 2017</start_date>
  <completion_date type="Actual">July 18, 2017</completion_date>
  <primary_completion_date type="Actual">July 18, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Validate that the production equivalent PM7100 System in conjunction with Adult Sensors (PMSENS71-A)</measure>
    <time_frame>Data collected from individual participant over 4 hour timeframe.</time_frame>
    <description>INVOS regional hemoglobin oxygen saturation (rSO2) performance will be compared to the calculated global field saturation (fSO2) value obtained from simultaneous collected arterial and jugular venous blood samples for the cerebral site.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Oxygen Deficiency</condition>
  <arm_group>
    <arm_group_label>Desaturation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volunteers undergo oxygen desaturation in order to determine the accuracy of the device over a clinical range of oxygen saturations 70 - 100%.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Desaturation</intervention_name>
    <description>The delivered gas mixture will be adjusted to decrease the displayed saturation of peripheral oxygen. Each desaturation steps are of approximately 5 minutes duration with reduction in pulse oximeter oxygen saturation from 100 to 70%.</description>
    <arm_group_label>Desaturation</arm_group_label>
    <other_name>INVOS Cerebral and Tissue Oximeter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy, male or female subjects between the ages of 18 to â‰¤46 years;

          2. Completion of a health screening for a medical history by a licensed physician, nurse
             practitioner or physician assistant;

          3. Minimum weight 40kg;

          4. BMI within range 18.0 - 30.0.

        Exclusion Criteria:

          1. Prior or known allergies to lidocaine (or similar pharmacologic agents, e.g.,
             Novocain) [self-reported];

          2. Prior known severe allergies to medical grade adhesive/tape (Band-Aid)
             [self-reported];

          3. Taking any medication other than birth control [self-reported];

          4. Is currently participating in, or has recently participated in (discontinued within 30
             days prior to the hypoxia procedure for this study) in an investigational drug,
             device, or biologic study [self-reported];

          5. Has a negative Allen's Test to confirm non-patency of the collateral artery [clinical
             assessment by PI or delegate];

          6. Has made a whole blood donation or has had at least 450 ml of blood drawn within 8
             weeks prior to the study procedure [self-reported];

          7. Is female with a positive pregnancy test [serum or urine], or is female and is
             unwilling to use effective birth control between the time of screening and study
             procedure or is breastfeeding;

          8. Has anemia [lab values specific for gender];

          9. Has a history of sickle cell trait or thalassemia [self-reported];

         10. Has an abnormal hemoglobin electrophoresis test [lab measurement];

         11. Has a positive urine cotinine test or urine drug screen or oral ethanol test [POC
             testing];

         12. Has a room air saturation less than 95% by pulse oximetry [measurement by PI or
             delegate];

         13. Has a clinically significant abnormal ECG [assessment by PI or delegate];

         14. Has a clinically significant abnormal pulmonary function test via spirometry
             [assessment by PI or delegate];

         15. Has a COHb greater than 3%, or MetHb greater than 2% [measured by venous blood sample
             co-oximetry]
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>46 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia Katilius</last_name>
    <role>Study Director</role>
    <affiliation>Medtronic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Hospital, HPPL</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

